UNSPSC 85543259: Supplement left neck lymphatic with synthetic substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left neck lymphatic with synthetic substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 07U24JZ

UNSPSC 85543259 Supplement left neck lymphatic with synthetic substitute, percutaneous endoscopic approach, Commodity tier, does not reflect the work state and local governments are currently buying. The code's nominal scope addresses a specific surgical procedure — lymphatic supplementation via endoscopic techniques — but the recent opportunities posted under this code span prison medical and pharmacy services, county-wide pharmacy benefit management, virtual primary and urgent care for county employees, peer support services for behavioral health workers, and emergency medical services medical direction. None of these solicitations involve lymphatic surgery or synthetic substitutes. The mismatch between the code's surgical nomenclature and the actual procurements posted under it suggests either a cataloging error in the state and local procurement database or the code's assignment to opportunities unrelated to its defined scope.

The recent-opportunity block shows activity in Georgia, Florida, and California, with issuing bodies including county governments (Muscogee County in Georgia, Collier County in Florida, Monroe County in Florida, San Mateo County in California) and municipal fire departments (Santa Monica Fire Department). No repeat buyers appear in the sample, and no procurement in this code block references set-asides for disadvantaged enterprises, though the Collier County RFP notes that local business preference and minority business enterprise certification status are evaluation criteria. The code shows little decision-relevant recent activity for business development purposes — the opportunities listed are healthcare service contracts and medical direction agreements that operate under fundamentally different procurement logics than the code's nominal product description would suggest.